CDH2 and gastric cancer: Eukaryotic translation initiation factor 5A2 (EIF5A2) (by up-regulating epithelial markers E-cadherin and β-cadherin, down-regulating mesenchymal markers Vimentin and N-cadherin mediate the EMT process to regulate the resistance of gastric cancer cells to cisplatin (Sun et al., 2018).